Organization: Jubilant Life Sciences
Co-chairman & MD: Hari S Bhartia
Revenue (Vaccines): Rs 483 crore
While its growth has been primarily driven by the generic pharmaceutical businesses, the Jubilant Life Sciences is also betting big on contract research. Jubilant LifeSciences is an integrated global pharmaceutical and lifesciences company engaged in manufacturing and supply of APIs, generics, specialty pharmaceuticals and lifescience ingredients. It also provides services in contract manufacturing and drug discovery and development.
The company's strength lies in its unique offerings of pharmaceutical and lifesciences products and services across the value chain.With 10 worldclass manufacturing facilities in India, US and Canada and a team of over 6,300 multicultural people across the globe, the company is committed to deliver value to its customers spread across 98 countries.The company is well recognized as a ‘Partner of Choice' by leading pharmaceuticals and lifesciences companies globally.
"Sustained strong performance in our radiopharmaceuticals business and normalization of CMO operations supported revenue growth in the pharmaceuticalssegment. Going forward,we expect the pharmaceuticals segment to drive revenue growth with improvement in profitability in key businesses across both segments," mentioned Mr Shyam S Bhartia, chairman and managing director and